Cargando…
Engineering the immune response to "self" for effective cancer immunotherapy
Autores principales: | Zhong, Shi, Malecek, Karolina, Moogk, Duane, Johnson, Laura A, Yu, Zhiya, Grigoryan, Arsen, Vega-Saenz de Miera, Eleazar, Darvishian, Farbod, Gu, Wei Jun, McGary, Katelyn, Huang, Kevin, Boyer, Joshua, Corse, Emily, Yongzhao, Shao, Rosenberg, Steven A, Restifo, Nicholas P, Cardozo, Timothy, Frey, Alan, Osman, Iman, Krogsgaard, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288589/ http://dx.doi.org/10.1186/2051-1426-2-S3-P22 |
Ejemplares similares
-
T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy
por: Krogsgaard, Michelle, et al.
Publicado: (2013) -
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
por: Moogk, Duane, et al.
Publicado: (2014) -
2081: Phenotypic characterization of the CD4+ T-cell response during anti-CTLA4 therapy with ipilimumab in melanoma patients
por: Sherani, Farha, et al.
Publicado: (2018) -
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts
por: Weiss, Sarah A., et al.
Publicado: (2016) -
Specific increase in T cell potency via structure-based design of a T cell receptor for adoptive immunotherapy
por: Malecek, Karolina, et al.
Publicado: (2014)